295 related articles for article (PubMed ID: 12804128)
1. Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: an open-label extension trial.
McConville B; Carrero L; Sweitzer D; Potter L; Chaney R; Foster K; Sorter M; Friedman L; Browne K
J Child Adolesc Psychopharmacol; 2003; 13(1):75-82. PubMed ID: 12804128
[TBL] [Abstract][Full Text] [Related]
2. Quetiapine alone and added to a mood stabilizer for serious mood disorders.
Sajatovic M; Brescan DW; Perez DE; DiGiovanni SK; Hattab H; Ray JB; Bingham CR
J Clin Psychiatry; 2001 Sep; 62(9):728-32. PubMed ID: 11681770
[TBL] [Abstract][Full Text] [Related]
3. A study of quetiapine: efficacy and tolerability in psychotic adolescents.
Shaw JA; Lewis JE; Pascal S; Sharma RK; Rodriguez RA; Guillen R; Pupo-Guillen M
J Child Adolesc Psychopharmacol; 2001; 11(4):415-24. PubMed ID: 11838824
[TBL] [Abstract][Full Text] [Related]
4. Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. Seroquel Trial 48 Study Group.
McManus DQ; Arvanitis LA; Kowalcyk BB
J Clin Psychiatry; 1999 May; 60(5):292-8. PubMed ID: 10362435
[TBL] [Abstract][Full Text] [Related]
5. Long-Term use of quetiapine in elderly patients with psychotic disorders.
Tariot PN; Salzman C; Yeung PP; Pultz J; Rak IW
Clin Ther; 2000 Sep; 22(9):1068-84. PubMed ID: 11048905
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders.
McConville BJ; Arvanitis LA; Thyrum PT; Yeh C; Wilkinson LA; Chaney RO; Foster KD; Sorter MT; Friedman LM; Brown KL; Heubi JE
J Clin Psychiatry; 2000 Apr; 61(4):252-60. PubMed ID: 10830145
[TBL] [Abstract][Full Text] [Related]
7. Open-label study of the effect of combination quetiapine/lithium therapy on lithium pharmacokinetics and tolerability.
Potkin SG; Thyrum PT; Bera R; Carreon D; Alva G; Kalali AH; Yeh C
Clin Ther; 2002 Nov; 24(11):1809-23. PubMed ID: 12501876
[TBL] [Abstract][Full Text] [Related]
8. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
[TBL] [Abstract][Full Text] [Related]
9. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials.
Buckley PF
Curr Med Res Opin; 2004 Sep; 20(9):1357-63. PubMed ID: 15383183
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study.
Mullen J; Jibson MD; Sweitzer D
Clin Ther; 2001 Nov; 23(11):1839-54. PubMed ID: 11768836
[TBL] [Abstract][Full Text] [Related]
12. Rapid quetiapine loading in youths with bipolar disorder.
Scheffer RE; Tripathi A; Kirkpatrick FG; Schultz T
J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):441-5. PubMed ID: 20973715
[TBL] [Abstract][Full Text] [Related]
13. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study.
Paleacu D; Barak Y; Mirecky I; Mazeh D
Int J Geriatr Psychiatry; 2008 Apr; 23(4):393-400. PubMed ID: 17879256
[TBL] [Abstract][Full Text] [Related]
14. [Generic quetiapine in the treatment of acute schizophrenia and schizoaffective disorder].
György B; Robert K; László C; Andrea J;
Neuropsychopharmacol Hung; 2008 Dec; 10(5):293-303. PubMed ID: 19419015
[TBL] [Abstract][Full Text] [Related]
15. Safety, tolerability, and efficacy of quetiapine in youth with schizophrenia or bipolar I disorder: a 26-week, open-label, continuation study.
Findling RL; Pathak S; Earley WR; Liu S; DelBello M
J Child Adolesc Psychopharmacol; 2013 Sep; 23(7):490-501. PubMed ID: 24024534
[TBL] [Abstract][Full Text] [Related]
16. Quetiapine treatment in an open trial in combat-related post-traumatic stress disorder with psychotic features.
Kozaric-Kovacic D; Pivac N
Int J Neuropsychopharmacol; 2007 Apr; 10(2):253-61. PubMed ID: 16945162
[TBL] [Abstract][Full Text] [Related]
17. The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine.
Potkin SG; Thyrum PT; Alva G; Bera R; Yeh C; Arvanitis LA
J Clin Psychopharmacol; 2002 Apr; 22(2):121-30. PubMed ID: 11910256
[TBL] [Abstract][Full Text] [Related]
18. Quetiapine in adolescents with non-affective psychotic disorders: an open-label trial.
Holzer L; Preuss U; Baumgartner L; Jaugey L; Urben S; Halfon O; Baumann P
Pharmacopsychiatry; 2011 May; 44(3):87-95. PubMed ID: 21318938
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, placebo-controlled study of the safety and tolerability of high-dose quetiapine in patients with persistent symptoms of schizophrenia or schizoaffective disorder.
Honer WG; MacEwan GW; Gendron A; Stip E; Labelle A; Williams R; Eriksson H;
J Clin Psychiatry; 2012 Jan; 73(1):13-20. PubMed ID: 21733490
[TBL] [Abstract][Full Text] [Related]
20. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group.
Arvanitis LA; Miller BG
Biol Psychiatry; 1997 Aug; 42(4):233-46. PubMed ID: 9270900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]